Lista de obras - Peter Fickert - Dominio Público Uruguay

24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis

artículo científico publicado en 2014

24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

artículo científico publicado en 2006

A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis

artículo científico publicado en 2007

Abnormal hepatic sinusoidal bile acid transport: new insights into the pathogenesis of cholestasis?

artículo científico publicado en 2001

Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation

scientific article published on 01 December 1996

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.

artículo científico publicado en 2003

Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.

artículo científico publicado en 2011

Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury.

artículo científico publicado en 2014

Animal models in primary biliary cirrhosis and primary sclerosing cholangitis

artículo científico publicado en 2015

Author Correction: Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis

scientific article published on 06 June 2019

Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.

artículo científico publicado en 2016

Bile acid-induced cholemic nephropathy

artículo científico publicado en 2015

Bile acids as modulators of gut microbiota linking dietary habits and inflammatory bowel disease: a potentially dangerous liaison

scientific article published on 24 February 2013

Bile acids as regulators of hepatic lipid and glucose metabolism

artículo científico publicado en 2010

Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF-1

scientific article published on 17 February 2019

Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice

artículo científico publicado en 2013

Biliary obstruction due to duodenojejunal intussusception in Peutz-Jeghers syndrome

artículo científico publicado en 1996

Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

scientific article published on 19 August 2019

CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice

artículo científico publicado en 2005

Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis

artículo científico publicado en 2020

Characterization of animal models for primary sclerosing cholangitis (PSC).

artículo científico publicado en 2014

Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.

artículo científico

Clinical-pathological conference series from the Medical University of Graz: case no. 151: 19-year-old student from Albania with emergency admission due to shock

artículo científico publicado en 2014

Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease

artículo científico publicado en 1997

Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans

artículo científico publicado en 2012

Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans

artículo científico publicado en 2005

Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.

artículo científico publicado en 2010

Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids

artículo científico publicado en 2005

Cytokine-independent repression of rodent Ntcp in obstructive cholestasis

artículo científico publicado en 2005

Differential effects of norUDCA and UDCA in obstructive cholestasis in mice

artículo científico publicado en 2013

Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output

artículo científico publicado en 2011

Emergency Double-Stenting and Surgery for the Successful Management of Massive Upper Gastrointestinal Bleeding Caused by Mycotic Aortic Aneurysm.

artículo científico publicado en 2015

Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.

artículo científico publicado en 1998

Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts

artículo científico publicado en 2009

Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids

artículo científico publicado en 2005

Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model

artículo científico publicado en 2012

Genetic disorders and molecular mechanisms in cholestatic liver disease--a clinical approach.

artículo científico publicado en 2001

Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy

scientific article published on 25 August 2011

Hepatobiliary transporter expression in human hepatocellular carcinoma.

artículo científico publicado en 2005

Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress

artículo científico publicado en 2007

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.

artículo científico publicado en 2001

Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice

artículo científico publicado en 2009

Increased carbohydrate-deficient transferrin during pregnancy: relation to sex hormones

artículo científico publicado en 1996

Inflammatory bowel disease alters intestinal bile acid transporter expression.

artículo científico publicado en 2014

Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis

article

Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronic hepatitis C.

artículo científico publicado en 1999

Intra-hepatic haematoma complicating transjugular intra-hepatic portosystemic shunt for Budd-Chiari syndrome associated with anti-phospholipid antibodies, aplastic anaemia and chronic hepatitis C

scientific article published on 01 July 2000

Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study.

artículo científico publicado en 2015

Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases

artículo científico publicado en 2008

Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.

artículo científico publicado en 2006

Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice

artículo científico publicado en 2014

Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.

artículo científico publicado en 2015

Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins

scientific article published on 01 April 2003

Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes

artículo científico publicado en 2005

Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.

artículo científico publicado en 2006

Molecular pathogenesis of chronic cholestatic liver disease: impact on novel therapeutic approaches.

artículo científico publicado en 2013

Mycophenolate mofetil in patients with Crohn's disease

artículo científico publicado en 1998

Mycosis as a cause of secondary sclerosing cholangitis requiring liver retransplantation

artículo científico publicado en 2011

New insights into autoimmune cholangitis through animal models

artículo científico publicado en 2010

No evidence for mutagenic effects of ribavirin: report of two normal pregnancies

artículo científico publicado en 2001

Oncosis represents the main type of cell death in mouse models of cholestasis

artículo científico publicado en 2005

Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice

artículo científico publicado en 2013

PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis

artículo científico publicado en 2012

Pathogenesis of primary sclerosing cholangitis.

artículo científico

Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.

artículo científico publicado en 2004

Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers

artículo científico publicado en 2005

Pleuro-Pulmonary Nocardiosis as Opportunistic Infection in a Patient with Chronic Hepatitis C under Combination Treatment with Pegylated Interferon, Ribavirin, and Boceprevir

artículo científico publicado en 2013

Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders.

artículo científico

Primary sclerosing cholangitis--the arteriosclerosis of the bile duct?

artículo científico publicado en 2007

Primary sclerosing cholangitis: new approaches to diagnosis, surveillance and treatment

artículo científico

Reply

artículo científico publicado en 2015

Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice

artículo científico publicado en 2008

Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model.

artículo científico publicado en 2016

Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver

artículo científico publicado en 2005

Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut-Liver Axis: A Case Control Study

scientific article published on 07 September 2020

Serum alkaline phosphatase levels accurately reflect cholestasis in mice

artículo científico publicado en 2015

Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice

artículo científico publicado en 2009

Signal Transducer and Activator of Transcription 3 Protects From Liver Injury and Fibrosis in a Mouse Model of Sclerosing Cholangitis

article

Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist)

artículo científico publicado en 1998

Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis.

artículo científico publicado en 2004

Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis

artículo científico publicado en 2017

Successful conservative management of acute hepatic failure following exertional heatstroke

artículo científico publicado en 2003

Successful management of acute portal vein thrombosis by low molecular weight heparin and oral anticoagulation

artículo científico publicado en 2002

Successful nonsurgical treatment of primary mucosa-associated lymphoid tissue lymphoma of colon presenting with multiple polypoid lesions

artículo científico publicado en 2000

Successful steroid treatment of idiopathic thrombocytopenic purpura after orthotopic liver transplantation for primary biliary cirrhosis.

artículo científico publicado en 1998

Sulphatation does not appear to be a protective mechanism to prevent oxysterol accumulation in humans and mice

artículo científico publicado en 2013

Targeting nuclear bile acid receptors for liver disease

artículo científico publicado en 2011

The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis

artículo científico publicado en 2015

The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice

artículo científico publicado en 2010

The role of the hepatocyte cytokeratin network in bile formation and resistance to bile acid challenge and cholestasis in mice.

artículo científico publicado en 2009

Thioguanine-induced symptomatic thrombocytopenia.

artículo científico publicado en 2004

Time to say goodbye to the drug or the model? - why do drugs fail to live up to their promise in bile duct ligated mice?

artículo científico publicado en 2013

Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patients

artículo científico publicado en 2011

Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats

artículo científico publicado en 1998

Vitamin D modulates biliary fibrosis in ABCB4-deficient mice

artículo científico publicado en 2014

When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis

artículo científico publicado en 2008

Will we ever model PSC? - "it's hard to be a PSC model!".

artículo científico publicado en 2011

[New molecular aspects of cholestatic liver diseases]

artículo científico publicado en 1999

Lista de obras de Peter Fickert

24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis

24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis

Abnormal hepatic sinusoidal bile acid transport: new insights into the pathogenesis of cholestasis?

Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.

Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.

Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury.

Animal models in primary biliary cirrhosis and primary sclerosing cholangitis

Author Correction: Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis

Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.

Bile acid-induced cholemic nephropathy

Bile acids as modulators of gut microbiota linking dietary habits and inflammatory bowel disease: a potentially dangerous liaison

Bile acids as regulators of hepatic lipid and glucose metabolism

Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF-1

Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice

Biliary obstruction due to duodenojejunal intussusception in Peutz-Jeghers syndrome

Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice

Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis

Characterization of animal models for primary sclerosing cholangitis (PSC).

Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.

Clinical-pathological conference series from the Medical University of Graz: case no. 151: 19-year-old student from Albania with emergency admission due to shock

Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease

Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans

Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans

Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.

Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids

Cytokine-independent repression of rodent Ntcp in obstructive cholestasis

Differential effects of norUDCA and UDCA in obstructive cholestasis in mice

Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output

Emergency Double-Stenting and Surgery for the Successful Management of Massive Upper Gastrointestinal Bleeding Caused by Mycotic Aortic Aneurysm.

Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.

Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts

Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids

Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model

Genetic disorders and molecular mechanisms in cholestatic liver disease--a clinical approach.

Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy

Hepatobiliary transporter expression in human hepatocellular carcinoma.

Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.

Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice

Increased carbohydrate-deficient transferrin during pregnancy: relation to sex hormones

Inflammatory bowel disease alters intestinal bile acid transporter expression.

Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis

Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronic hepatitis C.

Intra-hepatic haematoma complicating transjugular intra-hepatic portosystemic shunt for Budd-Chiari syndrome associated with anti-phospholipid antibodies, aplastic anaemia and chronic hepatitis C

Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study.

Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases

Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.

Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice

Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.

Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins

Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes

Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.

Molecular pathogenesis of chronic cholestatic liver disease: impact on novel therapeutic approaches.

Mycophenolate mofetil in patients with Crohn's disease

Mycosis as a cause of secondary sclerosing cholangitis requiring liver retransplantation

New insights into autoimmune cholangitis through animal models

No evidence for mutagenic effects of ribavirin: report of two normal pregnancies

Oncosis represents the main type of cell death in mouse models of cholestasis

Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice

PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis

Pathogenesis of primary sclerosing cholangitis.

Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.

Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers

Pleuro-Pulmonary Nocardiosis as Opportunistic Infection in a Patient with Chronic Hepatitis C under Combination Treatment with Pegylated Interferon, Ribavirin, and Boceprevir

Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders.

Primary sclerosing cholangitis--the arteriosclerosis of the bile duct?

Primary sclerosing cholangitis: new approaches to diagnosis, surveillance and treatment

Reply

Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice

Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model.

Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver

Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut-Liver Axis: A Case Control Study

Serum alkaline phosphatase levels accurately reflect cholestasis in mice

Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice

Signal Transducer and Activator of Transcription 3 Protects From Liver Injury and Fibrosis in a Mouse Model of Sclerosing Cholangitis

Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist)